The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 02, 2006
Filed:
Jan. 10, 2003
Shawn David Erickson, Leonia, NJ (US);
John J. Baldwin, Gwynedd Valley, PA (US);
Roland Ellwood Dolle, Iii, King of Prussia, PA (US);
James Inglese, Lansdale, PA (US);
Michael H. J. Ohlmeyer, Plainsboro, NJ (US);
Koc-kan Ho, Monmouth Junction, NJ (US);
Adolph C Bohnstedt, Burlington, NJ (US);
Steven G. Kultgen, Dayton, NJ (US);
Paolo Giovanni Martino Conti, Heesch, NL;
Dirk Leysen, Lommel, BE;
Jaap Van Der Louw, Oss, NL;
Shawn David Erickson, Leonia, NJ (US);
John J. Baldwin, Gwynedd Valley, PA (US);
Roland Ellwood Dolle, III, King of Prussia, PA (US);
James Inglese, Lansdale, PA (US);
Michael H. J. Ohlmeyer, Plainsboro, NJ (US);
Koc-Kan Ho, Monmouth Junction, NJ (US);
Adolph C Bohnstedt, Burlington, NJ (US);
Steven G. Kultgen, Dayton, NJ (US);
Paolo Giovanni Martino Conti, Heesch, NL;
Dirk Leysen, Lommel, BE;
Jaap van der Louw, Oss, NL;
Pharmacopeia Drug Discovery, Inc., Princeton, NJ (US);
Abstract
Compounds containing the pyrimidine nucleus and their use to treat diseases and conditions related to inappropriate Interleukin-8 receptor activity are disclosed. The compounds are of the formula IIn these compounds, Q is preferably unsubstituted and substituted heterocyclyl; U is usually hydrogen or fluorine; and V is preferably hydrogen, halogen, alkyl, —O—alkyl or —S-alkyl. A representative example is: